A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer.

A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer.

Item
http://www.wikidata.org/entity/Q54544613
Maintenance chemotherapy for advanced non-small-cell lung cancer: new life for an old ideaEconomic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic reviewCost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III studyCross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancerMaintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe.Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents.Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer.Clinical and economic review of erlotinib in non-small-cell lung cancer.A review of economic impact of targeted oral anticancer medications.Maintenance therapy in non-small cell lung cancer.Cost analysis of adverse events associated with non-small cell lung cancer management in France.Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
P2860

A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer.

Item
http://www.wikidata.org/entity/Q54544613
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
A cross-market cost comparison ...... ic non-small-cell lung cancer.
@en
A cross-market cost comparison ...... ic non-small-cell lung cancer.
@nl
type
label
A cross-market cost comparison ...... ic non-small-cell lung cancer.
@en
A cross-market cost comparison ...... ic non-small-cell lung cancer.
@nl
prefLabel
A cross-market cost comparison ...... ic non-small-cell lung cancer.
@en
A cross-market cost comparison ...... ic non-small-cell lung cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
A cross-market cost comparison ...... tic non-small-cell lung cancer
@en
P2093
P304
P31
P356
10.1016/J.LUNGCAN.2011.11.005
P433
P478
P50
P577
P698